MGTA
Magenta Therapeutics Inc
Price:  
0.7 
USD
Volume:  
376,060
United States | Biotechnology

MGTA Gross Margin

As of 2025-05-28, the Gross Margin of Magenta Therapeutics Inc (MGTA) is 7775.2%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

MGTA Gross Margin - Historical Value
DateValue
2022-12-31 7775.2%
2021-12-31 -
2020-12-31 -
2019-12-31 -
2018-12-31 -
2017-12-31 -
2016-12-31 -
-
-
-
MGTA Gross Margin - Peers Comparison